CAT grants
Cornell CAT grants fund collaborative life science research between Cornell faculty and NYS companies to advance early-stage biotech innovations toward commercialization and economic impact.
Funder: Cornell University
Due Dates (Anticipated): May 2027 (Full proposal, projected)
Funding Amounts: Typically matched to company contribution; specific award size varies by project.
Summary: Supports collaborative life science technology projects at Cornell, advancing innovations toward commercialization and economic impact in New York State.
Key Information: Requires partnership with a New York State for-profit company.
Description
The CAT grants, administered by the Center for Life Science Enterprise at the Cornell Institute of Biotechnology, are designed to accelerate early-stage life science technologies toward commercialization. This competitive program funds innovative biotechnology projects with strong potential for economic impact in New York State. Emphasizing collaboration, the program requires partnerships between Cornell faculty researchers and New York State-based for-profit companies to help move promising technologies closer to market readiness.
